Teriflunomide treatment reduces B cells in patients with MS

OBJECTIVE: To study the immunomodulatory effect of teriflunomide on innate and adaptive immune cell populations through a pilot, open-label, observational study in a cohort of patients with relapsing-remitting MS. METHODS: Blood lymphocytes were isolated from 10 patients with MS before and after 3 o...

Descripción completa

Detalles Bibliográficos
Autores principales: Gandoglia, Ilaria, Ivaldi, Federico, Laroni, Alice, Benvenuto, Federica, Solaro, Claudio, Mancardi, Gianluigi, Kerlero de Rosbo, Nicole, Uccelli, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656406/
https://www.ncbi.nlm.nih.gov/pubmed/29082295
http://dx.doi.org/10.1212/NXI.0000000000000403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656406/
https://www.ncbi.nlm.nih.gov/pubmed/29082295
http://dx.doi.org/10.1212/NXI.0000000000000403

Ejemplares similares